Listed

Cytokinetics Inc

CYTKNasdaqCIK 1061983HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$28.6m, Q2 FY2026
Operating income−$179.2m, Q2 FY2026
Net income−$198.8m, Q2 FY2026
Cytokinetics Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.4Revenue, Q3 FY2023, three months to 2023-09-30$378.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure1.7Revenue, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure0.8Revenue, Q1 FY2024, three months to 2024-03-31$835.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure0.2Revenue, Q2 FY2024, three months to 2024-06-30$249.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure0.5Revenue, Q3 FY2024, three months to 2024-09-30$463.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure16.9Revenue, Q4 FY2024, three months to 2024-12-31$16.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure1.6Revenue, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure66.8Revenue, Q2 FY2025, three months to 2025-06-30$66.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure1.9Revenue, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure17.8Revenue, Q4 FY2025, three months to 2025-12-31$17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure19.4Revenue, Q1 FY2026, three months to 2026-03-31$19.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure28.6Revenue, Q2 FY2026, three months to 2026-06-30$28.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Research and development$m82.5Research and development, Q3 FY2023, three months to 2023-09-30$82.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure85.0Research and development, Q4 FY2023, three months to 2023-12-31$85.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure81.6Research and development, Q1 FY2024, three months to 2024-03-31$81.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure79.6Research and development, Q2 FY2024, three months to 2024-06-30$79.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure84.6Research and development, Q3 FY2024, three months to 2024-09-30$84.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure93.6Research and development, Q4 FY2024, three months to 2024-12-31$93.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure98.3Research and development, Q1 FY2025, three months to 2025-03-31$98.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure110Research and development, Q2 FY2025, three months to 2025-06-30$110.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure99.2Research and development, Q3 FY2025, three months to 2025-09-30$99.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure104Research and development, Q4 FY2025, three months to 2025-12-31$104.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure95.5Research and development, Q1 FY2026, three months to 2026-03-31$95.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure97.8Research and development, Q2 FY2026, three months to 2026-06-30$97.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported57.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$57.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure65.7Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$65.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figurenot reportednot reported105Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$104.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure104Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$104.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Operating income$m(122)Operating income, Q3 FY2023, three months to 2023-09-30−$122.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure(127)Operating income, Q4 FY2023, three months to 2023-12-31−$127.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(126)Operating income, Q1 FY2024, three months to 2024-03-31−$126.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure(130)Operating income, Q2 FY2024, three months to 2024-06-30−$130.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure(141)Operating income, Q3 FY2024, three months to 2024-09-30−$140.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(139)Operating income, Q4 FY2024, three months to 2024-12-31−$139.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(156)Operating income, Q1 FY2025, three months to 2025-03-31−$155.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(112)Operating income, Q2 FY2025, three months to 2025-06-30−$111.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(167)Operating income, Q3 FY2025, three months to 2025-09-30−$166.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(178)Operating income, Q4 FY2025, three months to 2025-12-31−$178.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(184)Operating income, Q1 FY2026, three months to 2026-03-31−$183.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(179)Operating income, Q2 FY2026, three months to 2026-06-30−$179.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Interest expense$m7.1Interest expense, Q3 FY2023, three months to 2023-09-30$7.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure7.2Interest expense, Q4 FY2023, three months to 2023-12-31$7.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure7.1Interest expense, Q1 FY2024, three months to 2024-03-31$7.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure12.7Interest expense, Q2 FY2024, three months to 2024-06-30$12.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure8.9Interest expense, Q3 FY2024, three months to 2024-09-30$8.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure8.9Interest expense, Q4 FY2024, three months to 2024-12-31$8.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figurenot reported11.1Interest expense, Q2 FY2025, three months to 2025-06-30$11.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure11.4Interest expense, Q3 FY2025, three months to 2025-09-30$11.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure14.3Interest expense, Q4 FY2025, three months to 2025-12-31$14.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(129)Net income, Q3 FY2023, three months to 2023-09-30−$129.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure(137)Net income, Q4 FY2023, three months to 2023-12-31−$136.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(136)Net income, Q1 FY2024, three months to 2024-03-31−$135.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(143)Net income, Q2 FY2024, three months to 2024-06-30−$143.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(161)Net income, Q3 FY2024, three months to 2024-09-30−$160.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(150)Net income, Q4 FY2024, three months to 2024-12-31−$150.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(161)Net income, Q1 FY2025, three months to 2025-03-31−$161.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(134)Net income, Q2 FY2025, three months to 2025-06-30−$134.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(306)Net income, Q3 FY2025, three months to 2025-09-30−$306.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(183)Net income, Q4 FY2025, three months to 2025-12-31−$183.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(206)Net income, Q1 FY2026, three months to 2026-03-31−$206.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(199)Net income, Q2 FY2026, three months to 2026-06-30−$198.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Diluted EPS$ per share(1.35)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figurenot reported(1.33)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure(1.31)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure(1.36)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figurenot reported(1.36)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(1.12)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(2.55)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$2.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figurenot reported(1.67)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(1.50)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Basic EPS$ per share(1.35)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figurenot reported(1.33)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure(1.31)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure(1.36)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figurenot reported(1.36)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(1.12)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(2.55)Basic EPS, Q3 FY2025, three months to 2025-09-30−$2.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figurenot reported(1.67)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(1.50)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure

Balance sheet

Cash and equivalents$255.3m, Q2 FY2026
Long-term debt$248.2m, Q2 FY2026
Shareholders' equity−$173.5m, Q2 FY2026
Cytokinetics Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m99.7Cash and equivalents, Q3 FY2023, at 2023-09-30$99.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure113Cash and equivalents, FY2023, at 2023-12-31$113.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure120Cash and equivalents, Q1 FY2024, at 2024-03-31$120.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure190Cash and equivalents, Q2 FY2024, at 2024-06-30$190.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure46.9Cash and equivalents, Q3 FY2024, at 2024-09-30$46.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure94.9Cash and equivalents, FY2024, at 2024-12-31$94.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure73.7Cash and equivalents, Q1 FY2025, at 2025-03-31$73.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure74.9Cash and equivalents, Q2 FY2025, at 2025-06-30$74.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure225Cash and equivalents, Q3 FY2025, at 2025-09-30$225.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure123Cash and equivalents, FY2025, at 2025-12-31$122.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure130Cash and equivalents, Q1 FY2026, at 2026-03-31$129.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure255Cash and equivalents, Q2 FY2026, at 2026-06-30$255.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Current assets$m561Current assets, Q3 FY2023, at 2023-09-30$561.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure628Current assets, FY2023, at 2023-12-31$628.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure639Current assets, Q1 FY2024, at 2024-03-31$638.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure1,068Current assets, Q2 FY2024, at 2024-06-30$1.07bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure1,019Current assets, Q3 FY2024, at 2024-09-30$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure1,108Current assets, FY2024, at 2024-12-31$1.11bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure956Current assets, Q1 FY2025, at 2025-03-31$956.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure887Current assets, Q2 FY2025, at 2025-06-30$886.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure977Current assets, Q3 FY2025, at 2025-09-30$977.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure917Current assets, FY2025, at 2025-12-31$917.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure839Current assets, Q1 FY2026, at 2026-03-31$839.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure1,208Current assets, Q2 FY2026, at 2026-06-30$1.21bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Total assets$m741Total assets, Q3 FY2023, at 2023-09-30$740.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure824Total assets, FY2023, at 2023-12-31$824.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure808Total assets, Q1 FY2024, at 2024-03-31$808.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure1,524Total assets, Q2 FY2024, at 2024-06-30$1.52bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure1,436Total assets, Q3 FY2024, at 2024-09-30$1.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure1,402Total assets, FY2024, at 2024-12-31$1.40bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure1,264Total assets, Q1 FY2025, at 2025-03-31$1.26bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure1,226Total assets, Q2 FY2025, at 2025-06-30$1.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure1,437Total assets, Q3 FY2025, at 2025-09-30$1.44bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure1,425Total assets, FY2025, at 2025-12-31$1.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure1,273Total assets, Q1 FY2026, at 2026-03-31$1.27bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure1,925Total assets, Q2 FY2026, at 2026-06-30$1.92bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Current liabilities$m77.7Current liabilities, Q3 FY2023, at 2023-09-30$77.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure103Current liabilities, FY2023, at 2023-12-31$102.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure88.9Current liabilities, Q1 FY2024, at 2024-03-31$88.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure103Current liabilities, Q2 FY2024, at 2024-06-30$102.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure110Current liabilities, Q3 FY2024, at 2024-09-30$109.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure180Current liabilities, FY2024, at 2024-12-31$179.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure160Current liabilities, Q1 FY2025, at 2025-03-31$159.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure131Current liabilities, Q2 FY2025, at 2025-06-30$131.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure142Current liabilities, Q3 FY2025, at 2025-09-30$142.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure202Current liabilities, FY2025, at 2025-12-31$202.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure199Current liabilities, Q1 FY2026, at 2026-03-31$199.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure181Current liabilities, Q2 FY2026, at 2026-06-30$181.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Total liabilities$m1,179Total liabilities, Q3 FY2023, at 2023-09-30$1.18bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure1,211Total liabilities, FY2023, at 2023-12-31$1.21bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure1,204Total liabilities, Q1 FY2024, at 2024-03-31$1.20bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure1,415Total liabilities, Q2 FY2024, at 2024-06-30$1.42bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure1,450Total liabilities, Q3 FY2024, at 2024-09-30$1.45bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure1,537Total liabilities, FY2024, at 2024-12-31$1.54bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure1,530Total liabilities, Q1 FY2025, at 2025-03-31$1.53bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure1,594Total liabilities, Q2 FY2025, at 2025-06-30$1.59bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure1,958Total liabilities, Q3 FY2025, at 2025-09-30$1.96bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure2,084Total liabilities, FY2025, at 2025-12-31$2.08bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure2,100Total liabilities, Q1 FY2026, at 2026-03-31$2.10bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure2,098Total liabilities, Q2 FY2026, at 2026-06-30$2.10bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Long-term debt$m60.9Long-term debt, Q3 FY2023, at 2023-09-30$60.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure58.4Long-term debt, FY2023, at 2023-12-31$58.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure56.8Long-term debt, Q1 FY2024, at 2024-03-31$56.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure92.8Long-term debt, Q2 FY2024, at 2024-06-30$92.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure93.0Long-term debt, Q3 FY2024, at 2024-09-30$93.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure93.2Long-term debt, FY2024, at 2024-12-31$93.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure92.0Long-term debt, Q1 FY2025, at 2025-03-31$92.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure159Long-term debt, Q2 FY2025, at 2025-06-30$159.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure159Long-term debt, Q3 FY2025, at 2025-09-30$158.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure246Long-term debt, FY2025, at 2025-12-31$246.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure247Long-term debt, Q1 FY2026, at 2026-03-31$247.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure248Long-term debt, Q2 FY2026, at 2026-06-30$248.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Current portion of debt$mnot reported10.1Current portion of debt, FY2023, at 2023-12-31$10.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029206.Report this figure11.5Current portion of debt, Q1 FY2024, at 2024-03-31$11.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure11.5Current portion of debt, Q2 FY2024, at 2024-06-30$11.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure11.5Current portion of debt, Q3 FY2024, at 2024-09-30$11.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure11.5Current portion of debt, FY2024, at 2024-12-31$11.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure13.0Current portion of debt, Q1 FY2025, at 2025-03-31$13.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure14.4Current portion of debt, Q2 FY2025, at 2025-06-30$14.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure17.3Current portion of debt, Q3 FY2025, at 2025-09-30$17.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure41.2Current portion of debt, FY2025, at 2025-12-31$41.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure44.8Current portion of debt, Q1 FY2026, at 2026-03-31$44.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure27.4Current portion of debt, Q2 FY2026, at 2026-06-30$27.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure
Shareholders' equity$m(439)Shareholders' equity, Q3 FY2023, at 2023-09-30−$438.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure(386)Shareholders' equity, FY2023, at 2023-12-31−$386.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076495.Report this figure(396)Shareholders' equity, Q1 FY2024, at 2024-03-31−$396.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure109Shareholders' equity, Q2 FY2024, at 2024-06-30$108.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(13.9)Shareholders' equity, Q3 FY2024, at 2024-09-30−$13.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(135)Shareholders' equity, FY2024, at 2024-12-31−$135.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(266)Shareholders' equity, Q1 FY2025, at 2025-03-31−$266.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(369)Shareholders' equity, Q2 FY2025, at 2025-06-30−$368.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(521)Shareholders' equity, Q3 FY2025, at 2025-09-30−$521.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure(660)Shareholders' equity, FY2025, at 2025-12-31−$659.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(827)Shareholders' equity, Q1 FY2026, at 2026-03-31−$826.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure(173)Shareholders' equity, Q2 FY2026, at 2026-06-30−$173.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure

Cash flow

Operating cash flow−$159.8m, Q2 FY2026
Capital expenditure$4.3m, Q2 FY2026
Cytokinetics Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(96.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$96.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123283. Derived: 9-month figure less the 6-month figure.Report this figure(74.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$74.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(130)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$129.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure(99.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$99.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105108. Derived: 6-month figure less the 3-month figure.Report this figure(102)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$101.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-267059. Derived: 9-month figure less the 6-month figure.Report this figure(65.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$65.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(132)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$131.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(128)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$128.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338217. Derived: 6-month figure less the 3-month figure.Report this figure(108)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$107.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-267059. Derived: 9-month figure less the 6-month figure.Report this figure(143)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$142.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure(145)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$145.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure(160)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$159.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338217. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$220.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123283. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$77.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure1.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105108. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2024, three months to 2024-09-30$701.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-267059. Derived: 9-month figure less the 6-month figure.Report this figure1.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure5.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure4.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$4.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338217. Derived: 6-month figure less the 3-month figure.Report this figure9.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$9.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-267059. Derived: 9-month figure less the 6-month figure.Report this figure5.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$5.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076495. Derived: 12-month figure less the 9-month figure.Report this figure5.9Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure4.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338217. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)132,086, Q2 FY2026
Cytokinetics Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares93.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3093,758 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0000950170-23-058914.Report this figure95.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3195,164 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0000950170-24-057805.Report this figure95.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3095,755 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0000950170-24-094743.Report this figure96.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3096,071 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123283.Report this figure102Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31101,924 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064529.Report this figure109Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30109,240 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105108.Report this figure118Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30117,685 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure118Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31118,496 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure119Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30119,457 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure120Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30119,982 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-267059.Report this figure123Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31123,273 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206364.Report this figure132Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30132,086 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure

Shares outstanding: 139.02mShares outstanding, period not labelled, at 2026-08-04139,023,418 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338217.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.